BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12505065)

  • 1. Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.
    Macfelda K; Weiss TW; Kaun C; Breuss JM; Zorn G; Oberndorfer U; Voegele-Kadletz M; Huber-Beckmann R; Ullrich R; Binder BR; Losert UM; Maurer G; Pacher R; Huber K; Wojta J
    J Mol Cell Cardiol; 2002 Dec; 34(12):1681-91. PubMed ID: 12505065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
    Weiss TW; Speidl WS; Kaun C; Rega G; Springer C; Macfelda K; Losert UM; Grant SL; Marro ML; Rhodes AD; Fuernkranz A; Bialy J; Ullrich R; Holzmann P; Pacher R; Maurer G; Huber K; Wojta J
    Cardiovasc Res; 2003 Sep; 59(3):628-38. PubMed ID: 14499864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
    Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor.
    Campbell IK; Wojta J; Novak U; Hamilton JA
    Biochim Biophys Acta; 1994 Jul; 1226(3):277-85. PubMed ID: 8054359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
    Xiao Y; Bunn CL; Bartold PM
    J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta.
    Jarai R; Kaun C; Weiss TW; Speidl WS; Rychli K; Maurer G; Huber K; Wojta J
    J Cell Mol Med; 2009; 13(11-12):4415-21. PubMed ID: 19228263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta.
    Hannocks MJ; Oliver L; Gabrilove JL; Wilson EL
    Blood; 1992 Mar; 79(5):1178-84. PubMed ID: 1536945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
    Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
    Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
    Cheng SL; Shen V; Peck WA
    Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells.
    Wilson HM; Haites NE; Booth NA
    Exp Nephrol; 1997; 5(3):233-8. PubMed ID: 9208283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
    Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.
    van Hinsbergh VW; Vermeer M; Koolwijk P; Grimbergen J; Kooistra T
    Blood; 1994 Nov; 84(9):2984-91. PubMed ID: 7949170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta).
    Tietze L; Elbrecht A; Schauerte C; Klosterhalfen B; Amo-Takyi B; Gehlen J; Winkeltau G; Mittermayer C; Handt S
    Thromb Haemost; 1998 Feb; 79(2):362-70. PubMed ID: 9493592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.
    Demyanets S; Kaun C; Pentz R; Krychtiuk KA; Rauscher S; Pfaffenberger S; Zuckermann A; Aliabadi A; Gröger M; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2013 Jul; 60():16-26. PubMed ID: 23567618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes.
    Kasza A; Kiss DL; Gopalan S; Xu W; Rydel RE; Koj A; Kordula T
    J Neurochem; 2002 Nov; 83(3):696-703. PubMed ID: 12390531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells.
    Kawai Y; Matsumoto Y; Watanabe K; Yamamoto H; Satoh K; Murata M; Handa M; Ikeda Y
    Blood; 1996 Mar; 87(6):2314-21. PubMed ID: 8630393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.